Skåne University Hospital
Lund, Sweden
35 recruiting
Showing 1–20 of 33 trials
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled178 locationsNCT05457283
Recruiting
Phase 3
Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
High-risk Melanoma
Uppsala University1,792 enrolled26 locationsNCT06488482
Recruiting
Phase 3
A Study to Learn More About How Well Sevabertinib (BAY 2927088) Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
HER2 MutationAdvanced Non-Small Cell Lung Cancer
Bayer278 enrolled283 locationsNCT06452277
Recruiting
Single-Stapled Technique for Colorectal Anastomosis
Colorectal, CancerColorectal AnastomosisAnastomotic Leakage+1 more
Umeå University500 enrolled5 locationsNCT07417358
Recruiting
Not Applicable
Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not
Pancreatic Neuroendocrine Tumor
Uppsala University200 enrolled4 locationsNCT07273409
Recruiting
Phase 2Phase 3
Antisecretory Factor Glioblastoma Phase 2
Glioblastoma
Peter Siesjö300 enrolled1 locationNCT05669820
Recruiting
Cerebellar Mutism Syndrome Study
Infratentorial NeoplasmsMutism
Rigshospitalet, Denmark1,000 enrolled30 locationsNCT02300766
Recruiting
Phase 2
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Breast Cancer
Karolinska University Hospital370 enrolled7 locationsNCT05900206
Recruiting
Phase 2
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Dedifferentiated Liposarcoma
Lund University Hospital33 enrolled4 locationsNCT06389799
Recruiting
Not Applicable
Preoperative Short-Course Radiation Therapy With PROtons Compared to Photons In High-Risk RECTal Cancer (PRORECT)
Rectal Cancer
Alexander Valdman254 enrolled9 locationsNCT04525989
Recruiting
Not Applicable
COMFI - a COMbined Fatigue Intervention
Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Spondyloarthritis (SpA)+1 more
The Danish Center for Expertise in Rheumatology40 enrolled2 locationsNCT06666452
Recruiting
Phase 3
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
High Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris800 enrolled142 locationsNCT04221035
Recruiting
Not Applicable
Selective Defunctioning Stoma in Low Anterior Resection for Rectal Cancer
Rectal Cancer
Skane University Hospital212 enrolled1 locationNCT06214988
Recruiting
The Swedish BioFINDER - Preclinical AD Study
Alzheimer DiseaseMild Cognitive ImpairmentMild Dementia
Skane University Hospital800 enrolled1 locationNCT06121544
Recruiting
The Swedish BioFINDER - Memory Clinic Study
Alzheimer DiseaseMild Cognitive ImpairmentLewy Body Disease+4 more
Skane University Hospital1,200 enrolled1 locationNCT06122415
Recruiting
Phase 3
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
Preeclampsia
Lina Bergman294 enrolled9 locationsNCT06033131
Recruiting
Not Applicable
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
Crohn's Disease
Esbjerg Hospital - University Hospital of Southern Denmark165 enrolled5 locationsNCT06882993
Recruiting
Phase 2
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Colon CancerColon NeoplasmLynch Syndrome
Ann-Sofie Backman150 enrolled8 locationsNCT04920149
Recruiting
Not Applicable
A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
Malignant Melanoma
Uppsala University1,300 enrolled20 locationsNCT03116412
Recruiting
Phase 1Phase 2
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Recurrent Prostate Cancer
SpectraCure AB66 enrolled4 locationsNCT03067051